Signal2026-07-01
ClinicalTrials.gov

[PHASE2] mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC

Part of

Cancer Immunotherapy And Combination Strategies

Open primary sourceSee the whole picture